Bank Julius Baer & Co. Ltd, Zurich Synlogic, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$1.63 - $2.55 $13,040 - $20,400	-8,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.45 - $4.1 $75 - $127	31 Added 0.39%	8,000 $24,000
Q2 2021 Jul 23, 2021	SELL	$3.0 - $4.39 $93 - $136	-31 Reduced 0.39%	7,969 $31,000
Q1 2021 May 10, 2021	SELL	$2.2 - $5.05 $4,807 - $11,034	-2,185 Reduced 21.45%	8,000 $29,000
Q4 2020 Feb 24, 2021	BUY	$1.85 - $2.54 $18,374 - $25,227	9,932 Added 3925.69%	10,185 $22,000
Q4 2020 Feb 12, 2021	SELL	$1.85 - $2.54 $36,531 - $50,157	-19,747 Reduced 98.74%	253 $22,000
Q3 2020 Nov 10, 2020	BUY	$1.85 - $2.57 $37,000 - $51,400	20,000 New	20,000 $40,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.